Rebecca Traub is a Neurology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 43 publications with 1,757 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
194 Finley Golf Course Rd
Chapel Hill, NC 275174400
Telephone
984-974-4401Registry record last updated 15 May 2019.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARGENX US, INC.Program year202516 payments
- GENZYME CORPORATIONProgram year20251 payment
- Alnylam Pharmaceuticals Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
86.7%Gabapentinoids52.9%Gabapentin52%Pregabalin41%Pregabalin Er8%Part D<11 patientsCholinesterase Inhibitor12.2%Pyridostigmine Bromide100%Part D≥18 patients+ 6 more classes in this area
Metabolism & gastrointestinal
6.9%Corticosteroid6.9%Prednisone100%Part D≥13 patientsMusculoskeletal
3.8%Muscle Relaxant3.8%Cyclobenzaprine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2021 per NIH RePORTER. The latest:
- Using Medicare Claims to Advance Our Understanding of Guillain-Barre Syndrome
Univ of North Carolina Chapel Hill
FY2021$427,625R21NS119867
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical and Electrodiagnostic Findings in Anti-myelin–Associated Glycoprotein Antibody Polyneuropathy: A Single Center Review
Journal of Clinical Neuromuscular Disease
2025 - Characterizing Guillain-Barré Risk Factors Among Traditional Medicare Beneficiaries
INQUIRY The Journal of Health Care Organization Provision and Financing
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”